Sort
39,280 grants matching “leukemia”
Data-driven models of hematological cell fate decision and differentiation
$340,384Carlo Piermarocchi · Michigan State University · R01 · FY2017 · GM
NMR Studies of Retroviral Nucleic Acid Binding Proteins
$340,371University Of Maryland Balt Co Campus · R01 · FY2004 · GM
Adenosine Analogs: Therapeutics for Hematologic Cancers
$340,365Northwestern University · R01 · FY2005 · CA
Role of POZ-zinc finger proteins in tumorigenesis.
$340,356Pier Paolo Pandolfi · Beth Israel Deaconess Medical Center · R01 · FY2010 · CA
Therapeutic Targeting of Human AML Stem Cells
$340,338Craig T. Jordan · University Of Colorado Denver · R35 · FY2020 · CA
Enhancing CAR-T cell activity against solid tumors by vaccine boosting through the chimeric receptor
$340,336Darrell J Irvine · Massachusetts Institute Of Technology · R01 · FY2021 · CA
Antibody V Gene Expression B Cell Lymphocytic Leukemia
$340,333Thomas J. Kipps · University Of California, San Diego · R37 · FY2010 · CA
Molecular Genetics of Segment Identity
$340,313Columbia University Health Sciences · R01 · FY2005 · GM
Cancer Stem Cell Targeting in Multiple Myeloma
$340,300William H Matsui · Johns Hopkins University · R01 · FY2010 · CA
Incorporating FLT3 inhibitors into AML treatment regimens
$340,300Mark J Levis · Johns Hopkins University · R01 · FY2009 · CA
Incorporating FLT3 inhibitors into AML treatment regimens
$340,300Mark J Levis · Johns Hopkins University · R01 · FY2010 · CA
Incorporating FLT3 inhibitors into AML treatment regimens
$340,300Mark J Levis · Johns Hopkins University · R01 · FY2008 · CA
Immunologic targets in Myeloid Leukemia
$340,300Hyam Isaac Levitsky · Johns Hopkins University · R01 · FY2010 · CA
Animal Modeling and Clinical Resources Core
$340,284David F Claxton · University Of Virginia · P01 · FY2016 · CA
Animal Modeling and Clinical Resources Core
$340,284David F Claxton · University Of Virginia · P01 · FY2017 · CA
Development of Novel Informative Preclinical Animal Models - CAPR Infrastructure
$340,244Shyam Sharan · Division Of Basic Sciences - Nci · ZIG · FY2024 · CA
Identifying and targeting evolutionary trajectories in cancer
$340,243Michael Hemann · Massachusetts Institute Of Technology · R01 · FY2019 · CA
PATHOLOGY AND BIOLOGY OF LEUKEMIA ONCOGENES
$340,225Stanford University · R01 · FY2003 · CA
Membrane protein target for leukemia therapy
$340,224Xunlei Kang · University Of Missouri-Columbia · R37 · FY2021 · CA
Membrane protein target for leukemia therapy
$340,224Xunlei Kang · University Of Missouri-Columbia · R37 · FY2020 · CA
Epigenetic Modulation of GvHD and GvL
$340,210John F Dipersio · Washington University · P50 · FY2013 · CA
Molecular Mechanisms of Impaired DAN Damage Response in Leukemia Pathogenesis
$340,176James J-D Hsieh · Sloan-Kettering Inst Can Research · R01 · FY2013 · CA
Mechanisms of T cell leukemia induction and maintenance
$340,155Iannis Aifantis · New York University School Of Medicine · R01 · FY2012 · CA
Mechanisms of T cell leukemia induction and maintenance
$340,155Iannis Aifantis · New York University School Of Medicine · R01 · FY2011 · CA
Mechanisms of T cell leukemia induction and maintenance
$340,155Iannis Aifantis · New York University School Of Medicine · R01 · FY2015 · CA